• Trust and credibility gaps with clinicians, payers, and administrators make it hard for new solutions to gain adoption
• Complex regulatory, privacy, and compliance landscapes (HIPAA, FDA, Stark/AKS) create hesitation and slow rollouts
• Fragmented, multi-stakeholder buying committees elongate sales cycles and dilute messaging
✓ 20–50% increase in qualified inbound leads within 3–6 months of launch
✓ 10–30% premium pricing justified by stronger authority and clearer value communication
✓ 18–35% faster enterprise sales cycles through improved stakeholder alignment and de-risked adoption playbooks